+++
title = "FAVO Capital Appoints Healthcare Leader Dr. Wael Barsoum to Board Amid Strategic Expansion"
date = "2025-09-29T14:56:30Z"
draft = false
summary = "FAVO Capital strengthens its governance with the appointment of healthcare executive Dr. Wael Barsoum to its board, signaling potential strategic moves into healthcare financing and enhanced oversight during sector-wide regulatory scrutiny."
description = "FAVO Capital appoints Dr. Wael Barsoum to board, signaling healthcare expansion. Former Cleveland Clinic Florida CEO brings healthcare innovation expertise to financial services firm."
source_link = "https://rss.investorbrandnetwork.com/nnw/networknewsbreaks-favo-capital-otc-favo-appoints-dr-wael-barsoum-as-independent-director/"
enclosure = "https://cdn.newsramp.app/genai/images/259/29/7d2b4f7f660035257cf85e68bdcd6584.png"
article_id = 238463
feed_item_id = 21515
qrcode = "https://cdn.newsramp.app/ibn/qrcode/259/29/kisshQb_.webp"
source = "InvestorBrandNetwork (IBN)"
+++

<p>FAVO Capital (OTC: FAVO) has appointed Dr. Wael Barsoum to its board of directors as an independent director, bringing decades of leadership experience from his roles as former president and CEO of Cleveland Clinic Florida and current president and chief transformation officer at Healthcare Outcomes Performance Company. His background in healthcare innovation, governance, and organizational growth positions him to contribute significantly to FAVO's strategic direction during a period of increasing regulatory scrutiny and investor expectations for robust corporate governance across financial sectors.</p><p>Shaun Quin, president of FAVO Capital, emphasized that Barsoum's addition reflects the company's commitment to building a board with the independence, depth, and experience necessary to guide FAVO's next chapter. This move underscores FAVO's focus on strengthening its governance framework as it continues to expand its operations across financial services and real estate. The appointment suggests potential strategic initiatives in healthcare financing or partnerships, aligning with the company's diversification efforts and Barsoum's extensive healthcare expertise, which could prove valuable for risk assessment and innovation in this specialized sector.</p><p>The company's financial services division provides alternative, revenue-based funding solutions to small and mid-sized businesses across the United States, having supported more than 10,000 businesses through the purchase of future receipts since its inception. Complementing its lending platform, FAVO is building a portfolio of selective real assets to strengthen its balance sheet and broaden its collateral base. Barsoum's independent perspective and healthcare leadership background could help FAVO navigate complex market dynamics while exploring new growth opportunities in alternative financing and asset management.</p><p>Headquartered in Fort Lauderdale, Florida, with additional operations in New York and the Dominican Republic, FAVO Capital maintains a commitment to financial transparency, sustainable growth, and long-term value creation for its shareholders. The company's dual focus on financial services and real assets, combined with strengthened board oversight, positions it to potentially capitalize on emerging trends in business financing. Investors can access the latest news and updates relating to FAVO in the company's <a href="https://nnw.fm/FAVO" rel="nofollow" target="_blank">newsroom</a>, which provides ongoing information about corporate developments and performance.</p>